Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The MAS proto-oncogene receptor (MASR), also known as MAS1, is a G protein-coupled receptor (GPCR) activated by angiotensin-(1–7). It is involved in vasodilation, anti-proliferative actions, anti-inflammatory responses, cardioprotection, and regulation of glucose homeostasis. The ACE2-Ang-(1–7)-MAS axis plays an important role in cardiovascular health and disease modulation such as myocardial remodeling and cancer progression. MASR acts as a functional antagonist to AGTR1.
Activation of Gq proteins, phospholipase C signaling pathway activation, downstream activation of ERK/MAPK, PI3K/AKT/mTOR, RHO family GTPases, suppression of NFκB signaling, modulation of vascular endothelial growth factor signaling.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MAS proto-oncogene receptor (MASR).